SpringWorks Therapeutics, Inc. financial data

Symbol
SWTX on Nasdaq
Location
100 Washington Boulevard, Stamford, CT
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2024 - Aug 7, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 729 % -42.3%
Debt-to-equity 15 % +18.7%
Return On Assets -48.8 % +1.77%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 74.3M shares +18.7%
Common Stock, Shares, Outstanding 74.3M shares +18.7%
Entity Public Float 1.6B USD +76.6%
Common Stock, Value, Issued 7K USD +16.7%
Weighted Average Number of Shares Outstanding, Basic 74.1M shares +18.7%
Weighted Average Number of Shares Outstanding, Diluted 74.1M shares +18.7%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 59.7M USD
Research and Development Expense 179M USD +24.9%
General and Administrative Expense 178M USD +47.9%
Costs and Expenses 115M USD +47.9%
Operating Income (Loss) -321M USD -3.4%
Nonoperating Income (Expense) 25.9M USD +50.8%
Net Income (Loss) Attributable to Parent -301M USD -1.06%
Earnings Per Share, Basic -4.44 USD/shares +56.8%
Earnings Per Share, Diluted -4.44 USD/shares +56.8%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 79.9M USD -30.5%
Marketable Securities, Current 525M USD +94.7%
Cash, Cash Equivalents, and Short-term Investments 522M USD +9.48%
Accounts Receivable, after Allowance for Credit Loss, Current 24.5M USD
Inventory, Net 7.72M USD
Assets, Current 431M USD -10.9%
Property, Plant and Equipment, Net 18.2M USD -0.18%
Operating Lease, Right-of-Use Asset 6.36M USD -5.93%
Other Assets, Noncurrent 15.4M USD +412%
Assets 617M USD +19.3%
Accounts Payable, Current 7.89M USD +128%
Employee-related Liabilities, Current 15M USD +22.6%
Accrued Liabilities, Current 45.7M USD +29.4%
Contract with Customer, Liability, Current 0 USD -100%
Liabilities, Current 54.5M USD +30%
Contract with Customer, Liability, Noncurrent 0 USD -100%
Operating Lease, Liability, Noncurrent 6.1M USD -10.2%
Other Liabilities, Noncurrent 14.7M USD +11091%
Liabilities 60.6M USD -8.02%
Accumulated Other Comprehensive Income (Loss), Net of Tax -520K USD -47.7%
Retained Earnings (Accumulated Deficit) -1.02B USD -41.7%
Stockholders' Equity Attributable to Parent 557M USD +23.3%
Liabilities and Equity 617M USD +19.3%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -78.9M USD -27.7%
Net Cash Provided by (Used in) Financing Activities -552K USD +70.1%
Net Cash Provided by (Used in) Investing Activities 21.5M USD -78.2%
Common Stock, Shares Authorized 150M shares 0%
Common Stock, Shares, Issued 74.6M shares +19%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -58M USD -266%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 80.5M USD -30.4%
Deferred Tax Assets, Valuation Allowance 227M USD +44%
Deferred Tax Assets, Gross 230M USD +44.6%
Operating Lease, Liability 7.06M USD +34.4%
Depreciation 253K USD +134%
Payments to Acquire Property, Plant, and Equipment 577K USD -80.6%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -301M USD -1.62%
Lessee, Operating Lease, Liability, to be Paid 8.03M USD +33.7%
Property, Plant and Equipment, Gross 20.6M USD +39%
Operating Lease, Liability, Current 958K USD +18.1%
Lessee, Operating Lease, Liability, to be Paid, Year Two 2M USD +73.1%
Lessee, Operating Lease, Liability, to be Paid, Year One 1.48M USD +88.5%
Operating Lease, Weighted Average Discount Rate, Percent 0.06 pure +47.6%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 970K USD +29%
Lessee, Operating Lease, Liability, to be Paid, Year Three 2M USD +69.1%
Deferred Tax Assets, Operating Loss Carryforwards 121M USD +30.1%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 1.9M USD +57%
Additional Paid in Capital 1.59B USD +35.2%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 729K USD +188%
Share-based Payment Arrangement, Expense 105M USD +25.1%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%